The DOSIS Diagnosis Objectives Strategy Intervention Sequence brand, founded in 2009 (France), from 306 sister brands and 4958 competing brands. DOSIS Diagnosis Objectives Strategy Intervention Sequence is a brand of Ipsen, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of Ipsen is FR0010259150. DOSIS Diagnosis Objectives Strategy Intervention Sequence belongs to the Drug Manufacturers business sector.
Share price and profitability of the share Ipsen (DOSIS Diagnosis Objectives Strategy Intervention Sequence)
Buy Ipsen share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Ipsen
(DOSIS Diagnosis Objectives Strategy Intervention Sequence)
over 5 years*
EUR 122.43
Stock market history Ipsen (DOSIS Diagnosis Objectives Strategy Intervention Sequence)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
